Report Detail
Global Rosacea Medicine Market Insights, Forecast to 2025
- RnM2946216 |
- 14 February, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
The global Rosacea Medicine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Rosacea Medicine market based on company, product type, end user and key regions.
This report studies the global market size of Rosacea Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Rosacea Medicine in these regions.
This research report categorizes the global Rosacea Medicine market by top players/brands, region, type and end user. This report also studies the global Rosacea Medicine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Galderma Laboratories
Allergan Inc.
Topix
Barrier Therapeutics, Inc
Bayer AG
PharmaDerm Pharmaceuticals, Inc
Bristol-Myers Squibb
Genentech, Inc.
GlaxoSmithKline Plc
Market size by Product
Prescription Medicine
OTC
Market size by End User
Oral Administration
External Application
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Rosacea Medicine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Rosacea Medicine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Rosacea Medicine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Rosacea Medicine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Rosacea Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Rosacea Medicine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Rosacea Medicine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Rosacea Medicine Market Size Growth Rate by Product
- 1.4.2 Prescription Medicine
- 1.4.3 OTC
- 1.5 Market by End User
- 1.5.1 Global Rosacea Medicine Market Size Growth Rate by End User
- 1.5.2 Oral Administration
- 1.5.3 External Application
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Rosacea Medicine Market Size
- 2.1.1 Global Rosacea Medicine Revenue 2014-2025
- 2.1.2 Global Rosacea Medicine Sales 2014-2025
- 2.2 Rosacea Medicine Growth Rate by Regions
- 2.2.1 Global Rosacea Medicine Sales by Regions
- 2.2.2 Global Rosacea Medicine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Rosacea Medicine Sales by Manufacturers
- 3.1.1 Rosacea Medicine Sales by Manufacturers
- 3.1.2 Rosacea Medicine Sales Market Share by Manufacturers
- 3.1.3 Global Rosacea Medicine Market Concentration Ratio (CR5 and HHI)
- 3.2 Rosacea Medicine Revenue by Manufacturers
- 3.2.1 Rosacea Medicine Revenue by Manufacturers (2014-2019)
- 3.2.2 Rosacea Medicine Revenue Share by Manufacturers (2014-2019)
- 3.3 Rosacea Medicine Price by Manufacturers
- 3.4 Rosacea Medicine Manufacturing Base Distribution, Product Types
- 3.4.1 Rosacea Medicine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Rosacea Medicine Product Type
- 3.4.3 Date of International Manufacturers Enter into Rosacea Medicine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Rosacea Medicine Sales by Product
- 4.2 Global Rosacea Medicine Revenue by Product
- 4.3 Rosacea Medicine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Rosacea Medicine Breakdown Data by End User
6 North America
- 6.1 North America Rosacea Medicine by Countries
- 6.1.1 North America Rosacea Medicine Sales by Countries
- 6.1.2 North America Rosacea Medicine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Rosacea Medicine by Product
- 6.3 North America Rosacea Medicine by End User
7 Europe
- 7.1 Europe Rosacea Medicine by Countries
- 7.1.1 Europe Rosacea Medicine Sales by Countries
- 7.1.2 Europe Rosacea Medicine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Rosacea Medicine by Product
- 7.3 Europe Rosacea Medicine by End User
8 Asia Pacific
- 8.1 Asia Pacific Rosacea Medicine by Countries
- 8.1.1 Asia Pacific Rosacea Medicine Sales by Countries
- 8.1.2 Asia Pacific Rosacea Medicine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Rosacea Medicine by Product
- 8.3 Asia Pacific Rosacea Medicine by End User
9 Central & South America
- 9.1 Central & South America Rosacea Medicine by Countries
- 9.1.1 Central & South America Rosacea Medicine Sales by Countries
- 9.1.2 Central & South America Rosacea Medicine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Rosacea Medicine by Product
- 9.3 Central & South America Rosacea Medicine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Rosacea Medicine by Countries
- 10.1.1 Middle East and Africa Rosacea Medicine Sales by Countries
- 10.1.2 Middle East and Africa Rosacea Medicine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Rosacea Medicine by Product
- 10.3 Middle East and Africa Rosacea Medicine by End User
11 Company Profiles
- 11.1 Galderma Laboratories
- 11.1.1 Galderma Laboratories Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Galderma Laboratories Rosacea Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Galderma Laboratories Rosacea Medicine Products Offered
- 11.1.5 Galderma Laboratories Recent Development
- 11.2 Allergan Inc.
- 11.2.1 Allergan Inc. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Allergan Inc. Rosacea Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Allergan Inc. Rosacea Medicine Products Offered
- 11.2.5 Allergan Inc. Recent Development
- 11.3 Topix
- 11.3.1 Topix Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Topix Rosacea Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Topix Rosacea Medicine Products Offered
- 11.3.5 Topix Recent Development
- 11.4 Barrier Therapeutics, Inc
- 11.4.1 Barrier Therapeutics, Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Barrier Therapeutics, Inc Rosacea Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Barrier Therapeutics, Inc Rosacea Medicine Products Offered
- 11.4.5 Barrier Therapeutics, Inc Recent Development
- 11.5 Bayer AG
- 11.5.1 Bayer AG Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Bayer AG Rosacea Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Bayer AG Rosacea Medicine Products Offered
- 11.5.5 Bayer AG Recent Development
- 11.6 PharmaDerm Pharmaceuticals, Inc
- 11.6.1 PharmaDerm Pharmaceuticals, Inc Company Details
- 11.6.2 Company Business Overview
- 11.6.3 PharmaDerm Pharmaceuticals, Inc Rosacea Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 PharmaDerm Pharmaceuticals, Inc Rosacea Medicine Products Offered
- 11.6.5 PharmaDerm Pharmaceuticals, Inc Recent Development
- 11.7 Bristol-Myers Squibb
- 11.7.1 Bristol-Myers Squibb Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Bristol-Myers Squibb Rosacea Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Bristol-Myers Squibb Rosacea Medicine Products Offered
- 11.7.5 Bristol-Myers Squibb Recent Development
- 11.8 Genentech, Inc.
- 11.8.1 Genentech, Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Genentech, Inc. Rosacea Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Genentech, Inc. Rosacea Medicine Products Offered
- 11.8.5 Genentech, Inc. Recent Development
- 11.9 GlaxoSmithKline Plc
- 11.9.1 GlaxoSmithKline Plc Company Details
- 11.9.2 Company Business Overview
- 11.9.3 GlaxoSmithKline Plc Rosacea Medicine Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 GlaxoSmithKline Plc Rosacea Medicine Products Offered
- 11.9.5 GlaxoSmithKline Plc Recent Development
12 Future Forecast
- 12.1 Rosacea Medicine Market Forecast by Regions
- 12.1.1 Global Rosacea Medicine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Rosacea Medicine Revenue Forecast by Regions 2019-2025
- 12.2 Rosacea Medicine Market Forecast by Product
- 12.2.1 Global Rosacea Medicine Sales Forecast by Product 2019-2025
- 12.2.2 Global Rosacea Medicine Revenue Forecast by Product 2019-2025
- 12.3 Rosacea Medicine Market Forecast by End User
- 12.4 North America Rosacea Medicine Forecast
- 12.5 Europe Rosacea Medicine Forecast
- 12.6 Asia Pacific Rosacea Medicine Forecast
- 12.7 Central & South America Rosacea Medicine Forecast
- 12.8 Middle East and Africa Rosacea Medicine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Rosacea Medicine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Rosacea Medicine . Industry analysis & Market Report on Rosacea Medicine is a syndicated market report, published as Global Rosacea Medicine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Rosacea Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
